Acumen Pharmaceuticals, Inc. Banner Image

Acumen Pharmaceuticals, Inc.

  • Ticker ABOS
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Acumen Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Charlottesville, Virginia
Acumen, headquartered in Charlottesville, VA, with clinical operations based in Carmel, IN, is a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD). Acumen’s scientific founders pioneered research on AβOs, which a growing body of evidence indicates are early and persistentMore triggers of Alzheimer’s disease pathology. Acumen is currently focused on advancing its investigational product candidate, ACU193, a humanized monoclonal antibody that selectively targets toxic soluble AβOs in INTERCEPT-AD, a Phase 1 clinical trial involving early Alzheimer’s disease patients.
5.0 / 5.0 (1)

Acumen Pharmaceuticals, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Acumen Pharmaceuticals, Inc.

Most Recent Annual Report

Acumen Pharmaceuticals, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Acumen Pharmaceuticals, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!